Feds demand $1.8 billion from J&J to resolve Risperdal civil claims

WASHINGTON — The U.S. government has demanded that Johnson & Johnson raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the antipsychotic Risperdal, Bloomberg reported.

The Justice Department is demanding that J&J pay about $1.8 billion to resolve the civil claims by the U.S. and some states, according to the article.

The demand came after the Justice Department and states decided that a $1 billion settlement that had been negotiated by the U.S. Attorney’s Office in Philadelphia in late December wasn’t adequate.